At Vyriad, innovation is driven by a dedicated team fueled by both professional and personal motivations. Heather Bakalyar, Director of Intellectual Property (IP), is the perfect embodiment of this spirit. Her personal battle with cancer has given her work at Vyriad a deeper significance, where she blends her extensive background in intellectual property and her passion for molecular biology with a cause that’s close to her heart.

Everyone at Vyriad shares a common goal: to advance targeted genetic treatments quickly and effectively. “Having access to information and the best analytical tools is essential to our operations in scaling our viral-based gene therapy platform,” says Heather. “Oncology is a fast-moving field. It’s a race to get cutting-edge technology to patients who need it the most.”

Driven by this urgency, Heather and her colleagues turned to Patsnap for a research solution that combined user-friendliness with exceptional power and speed in delivering critical information.   

Having surveyed other tools, Heather finds that Patsnap’s AI-powered suite outperforms in terms of its capabilities, cost, and ease of use. She notes the dramatic improvement in her team’s productivity, saying, “projects that once seemed undoable due to their scope are now accelerated with Patsnap. The integration of sequence searching with patent analysis makes it possible for my team to analyze hundreds of sequences and their prior art in a matter of minutes. With Patsnap, discovery projects that took up to 3 weeks can now be done in under 2 days, helping us quickly get to answers regarding novelty and FTO.” The time saved allows Heather and her team to focus on more strategic and creative aspects of their work to ensure only the most viable candidates move on to development.